These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 22902638

  • 21. Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes.
    Moggs JG, Murphy TC, Lim FL, Moore DJ, Stuckey R, Antrobus K, Kimber I, Orphanides G.
    J Mol Endocrinol; 2005 Apr; 34(2):535-51. PubMed ID: 15821115
    [Abstract] [Full Text] [Related]

  • 22. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Identification of candidate methylation-responsive genes in ovarian cancer.
    Menendez L, Walker D, Matyunina LV, Dickerson EB, Bowen NJ, Polavarapu N, Benigno BB, McDonald JF.
    Mol Cancer; 2007 Jan 25; 6():10. PubMed ID: 17254359
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Chronic oxidative stress causes estrogen-independent aggressive phenotype, and epigenetic inactivation of estrogen receptor alpha in MCF-7 breast cancer cells.
    Mahalingaiah PK, Ponnusamy L, Singh KP.
    Breast Cancer Res Treat; 2015 Aug 25; 153(1):41-56. PubMed ID: 26208486
    [Abstract] [Full Text] [Related]

  • 30. Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells.
    Chang YW, Singh KP.
    PLoS One; 2017 Aug 25; 12(3):e0174227. PubMed ID: 28323900
    [Abstract] [Full Text] [Related]

  • 31. Screening for epigenetically masked genes in colorectal cancer Using 5-Aza-2'-deoxycytidine, microarray and gene expression profile.
    Khamas A, Ishikawa T, Shimokawa K, Mogushi K, Iida S, Ishiguro M, Mizushima H, Tanaka H, Uetake H, Sugihara K.
    Cancer Genomics Proteomics; 2012 Aug 25; 9(2):67-75. PubMed ID: 22399497
    [Abstract] [Full Text] [Related]

  • 32. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies.
    Gallagher WM, Bergin OE, Rafferty M, Kelly ZD, Nolan IM, Fox EJ, Culhane AC, McArdle L, Fraga MF, Hughes L, Currid CA, O'Mahony F, Byrne A, Murphy AA, Moss C, McDonnell S, Stallings RL, Plumb JA, Esteller M, Brown R, Dervan PA, Easty DJ.
    Carcinogenesis; 2005 Nov 25; 26(11):1856-67. PubMed ID: 15958521
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Insights into significant pathways and gene interaction networks underlying breast cancer cell line MCF-7 treated with 17β-estradiol (E2).
    Huan J, Wang L, Xing L, Qin X, Feng L, Pan X, Zhu L.
    Gene; 2014 Jan 01; 533(1):346-55. PubMed ID: 23978611
    [Abstract] [Full Text] [Related]

  • 35. Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas.
    Wargon V, Fernandez SV, Goin M, Giulianelli S, Russo J, Lanari C.
    Breast Cancer Res Treat; 2011 Apr 01; 126(2):319-32. PubMed ID: 20440553
    [Abstract] [Full Text] [Related]

  • 36. Genome-wide profiling in melatonin-exposed human breast cancer cell lines identifies differentially methylated genes involved in the anticancer effect of melatonin.
    Lee SE, Kim SJ, Yoon HJ, Yu SY, Yang H, Jeong SI, Hwang SY, Park CS, Park YS.
    J Pineal Res; 2013 Jan 01; 54(1):80-8. PubMed ID: 22856590
    [Abstract] [Full Text] [Related]

  • 37. Tamoxifen epigenetically modulates CXCL12 expression in MCF-7 breast cancer cells.
    Pietkiewicz PP, Lutkowska A, Lianeri M, Jagodzinski PP.
    Biomed Pharmacother; 2010 Jan 01; 64(1):54-7. PubMed ID: 19748759
    [Abstract] [Full Text] [Related]

  • 38. Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation.
    Stender JD, Frasor J, Komm B, Chang KC, Kraus WL, Katzenellenbogen BS.
    Mol Endocrinol; 2007 Sep 01; 21(9):2112-23. PubMed ID: 17550982
    [Abstract] [Full Text] [Related]

  • 39. Early membrane initiated transcriptional effects of estrogens in breast cancer cells: First pharmacological evidence for a novel membrane estrogen receptor element (ERx).
    Kampa M, Notas G, Pelekanou V, Troullinaki M, Andrianaki M, Azariadis K, Kampouri E, Lavrentaki K, Castanas E.
    Steroids; 2012 Aug 01; 77(10):959-67. PubMed ID: 22406407
    [Abstract] [Full Text] [Related]

  • 40. Identification of novel epigenetically inactivated gene PAMR1 in breast carcinoma.
    Lo PH, Tanikawa C, Katagiri T, Nakamura Y, Matsuda K.
    Oncol Rep; 2015 Jan 01; 33(1):267-73. PubMed ID: 25370079
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.